Burn Fat.
Build Muscle.
Simultaneously.

Natural body recomposition — losing fat and gaining muscle at the same time — is extraordinarily difficult under normal physiological conditions. The reason comes down to a fundamental conflict between anabolic and catabolic signaling. Building muscle requires a caloric surplus that drives anabolic pathways (mTOR, protein synthesis). Losing fat requires a caloric deficit that triggers catabolic pathways (lipolysis, protein breakdown for energy). These signals directly oppose each other, which is why the standard advice has always been to bulk and cut in separate phases.

Growth hormone peptides solve this conflict at the signaling level. When you amplify your natural GH pulse with CJC-1295 and Ipamorelin, you activate the GH/IGF-1 axis independently of caloric intake. GH is directly lipolytic — it activates hormone-sensitive lipase in adipocytes, mobilizing stored triglycerides for oxidation even during a moderate caloric surplus. Simultaneously, the IGF-1 that GH stimulates in the liver directly binds IGF-1 receptors on skeletal muscle, activating mTOR and protein synthesis without requiring the insulin spike that normally accompanies it. This is the peptide recomp mechanism: anabolic signaling and lipolysis occurring together — not because you're eating more, but because your GH axis is running at a level it hasn't seen since your 20s.

IGF-1 and the Muscle Protein Synthesis Cascade

IGF-1 LR3, the extended half-life variant, is the downstream executor of the GH signal. Native IGF-1 has a half-life of approximately 10 minutes because it rapidly binds IGF-binding proteins (IGFBPs) that neutralize it. The arginine-3 substitution in IGF-1 LR3 prevents this IGFBP binding, extending the active half-life to 20–30 hours and allowing it to reach muscle tissue at meaningful concentrations.

At the muscle cell, IGF-1 LR3 binds the IGF-1 receptor and activates the PI3K/Akt/mTOR pathway — the master regulator of muscle protein synthesis. Uniquely, IGF-1 LR3 can stimulate satellite cell proliferation and differentiation, a process called muscle hyperplasia. This is distinct from the hypertrophy (enlarging existing cells) that exercise produces. Hyperplasia is the creation of new muscle fibers — a significantly more powerful mechanism that explains why experienced users report muscle gains that would be impossible naturally.

Insulin Sensitivity and Nutrient Partitioning

The metabolic foundation of peptide-assisted recomposition is insulin sensitivity. When GH and IGF-1 levels are optimized, insulin sensitivity at the muscle improves dramatically — meaning more glucose and amino acids are directed to muscle tissue rather than fat cells. MOTS-c enhances this effect further by activating AMPK (AMP-activated protein kinase), the metabolic master switch that mimics caloric restriction and exercise at the cellular level. The net result is a body that preferentially partitions nutrients toward muscle building and away from fat storage — even when eating at maintenance or a slight surplus.

Why CJC-1295 / Ipamorelin Is Specifically Ideal

Not all GH-stimulating approaches are equivalent. Pharmaceutical HGH administration is continuous and non-pulsatile — it elevates GH steadily, which blunts natural GH receptor sensitivity over time and eventually suppresses endogenous production. CJC-1295 + Ipamorelin works differently: it amplifies the natural pulsatile GH secretion that the body's own hypothalamus-pituitary axis produces.

Pulsatile GH secretion is physiologically critical. GH receptors in muscle, adipose tissue, and liver require periods of low GH between pulses to reset and maintain full sensitivity. By amplifying the body's own pituitary pulses rather than imposing steady-state exogenous GH, CJC-1295/Ipamorelin preserves receptor sensitivity, does not suppress endogenous production, and produces a more physiological hormonal environment. The nightly dosing aligns with the natural GH peak that occurs during slow-wave sleep — amplifying it 8–10× during the window when the body is already primed for repair and anabolism.

The 12-Week Minimum Commitment

Body recomposition with peptides requires a minimum 12-week commitment because the changes being driven are structural. Fat oxidation takes weeks to produce visible results as millions of adipocytes reduce in size. Muscle fiber hypertrophy requires progressive mechanical stimulus and repeated protein synthesis cycles over weeks. Satellite cell proliferation (from IGF-1 LR3) and the subsequent integration of new muscle fibers takes 4–8 weeks per cycle. The hormonal environment established by consistent nightly GH pulsing builds cumulatively — the peptide's effects compound over time rather than being static.

Users who judge the stack after 3–4 weeks are evaluating it at the adaptation phase. The most significant body composition changes — visible waist reduction, measurable lean mass gain, improved vascularity — occur in the 5–10 week window. This is why every serious protocol specifies 12 weeks minimum, with optimal results appearing in the 3–6 month range for advanced recomposition goals.